Indeed, a search at (as of, Sep 14), employing cardiovascular disease and GLP-1 as keywords, returns 112 records comprising 42% completed, 39% recruiting, 8% not yet recruiting, 6% active, but not yet recruiting, 4% terminated, and 1% withdraw studies
The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript
Obesity 26(12):18341840 Bessesen DH, Van Gaal LF (2018) Progress and challenges in anti-obesity pharmacotherapy
And if you are currently dealing with it, or worried about dealing with it, you need real answers, not vague reassurance
& Cherney, D
To understand tirzepatide-specific timing, how fast tirzepatide works covers the pharmacokinetic details, and how long it takes for tirzepatide to work addresses onset expectations